A radiobiological comparison of hypo-fractionation versus conventional fractionation for breast cancer 3D-conformal radiation therapy
- PMID: 34046218
- PMCID: PMC8149130
- DOI: 10.5603/RPOR.a2021.0015
A radiobiological comparison of hypo-fractionation versus conventional fractionation for breast cancer 3D-conformal radiation therapy
Abstract
Background: The present research was aimed to compare the toxicity and effectiveness of conventional fractionated radiotherapy versus hypo-fractionated radiotherapy in breast cancer utilizing a radiobiological model.
Materials and methods: Thirty-five left-sided breast cancer patients without involvement of the supraclavicular and axillary lymph nodes (with the nodal stage of N0) that had been treated with conventional or hypo-fractionated were incorporated in this study. A radiobiological model was performed to foretell normal tissue complication probability (NTCP) and tumor control probability (TCP).
Results: The data represented that TCP values for conventional and hypo-fractionated regimens were 99.16 ± 0.09 and 95.96 ± 0.48, respectively (p = 0.00). Moreover, the NTCP values of the lung for conventional and hypo-fractionated treatment were 0.024 versus 0.13 (p = 0.035), respectively. Also, NTCP values of the heart were equal to zero for both regimens.
Conclusion: In summary, hypo-fractionated regimens had comparable efficacy to conventional fraction radiation therapy in the case of dosimetry parameters for patients who had left breast cancer. But, utilizing the radiobiological model, conventional fractionated regimens presented better results compared to hypo-fractionated regimens.
Keywords: 3D-conformal radiation therapy; breast cancer; conventional fractionation; hypo-fractionation; radiobiological model.
© 2021 Greater Poland Cancer Centre.
Conflict of interest statement
Conflict of interest The authors of this article have no conflicts of interest to report.
Figures
Similar articles
-
Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer.Australas Phys Eng Sci Med. 2009 Jun;32(2):51-61. doi: 10.1007/BF03178629. Australas Phys Eng Sci Med. 2009. PMID: 19623855
-
Comparison of Radiobiological Models for Radiation Therapy Plans of Prostate Cancer: Three-dimensional Conformal versus Intensity Modulated Radiation Therapy.J Biomed Phys Eng. 2019 Jun 1;9(3):267-278. doi: 10.31661/jbpe.v9i3Jun.655. eCollection 2019 Jun. J Biomed Phys Eng. 2019. PMID: 31341872 Free PMC article.
-
Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.Phys Med. 2019 Jun;62:41-46. doi: 10.1016/j.ejmp.2019.04.017. Epub 2019 May 6. Phys Med. 2019. PMID: 31153397
-
Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity-A Narrative Review.Front Oncol. 2022 Apr 7;12:862819. doi: 10.3389/fonc.2022.862819. eCollection 2022. Front Oncol. 2022. PMID: 35463375 Free PMC article. Review.
-
Breast cancer radiobiology: The renaissance of whole breast radiation fractionation (Review).Mol Clin Oncol. 2024 Oct 22;21(6):97. doi: 10.3892/mco.2024.2795. eCollection 2024 Dec. Mol Clin Oncol. 2024. PMID: 39484288 Free PMC article. Review.
Cited by
-
Optimization of the Dose-Volume Effect Parameter "a" in EUD-Based TCP Models for Breast Cancer Radiotherapy.Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251329103. doi: 10.1177/15330338251329103. Epub 2025 Mar 31. Technol Cancer Res Treat. 2025. PMID: 40165476 Free PMC article.
-
Dosimetric and radiobiological comparison between conventional and hypofractionated breast treatment plans using the Halcyon system.Front Oncol. 2023 Sep 26;13:1259416. doi: 10.3389/fonc.2023.1259416. eCollection 2023. Front Oncol. 2023. PMID: 37841437 Free PMC article.
-
Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer.J Appl Clin Med Phys. 2022 Aug;23(8):e13706. doi: 10.1002/acm2.13706. Epub 2022 Jun 21. J Appl Clin Med Phys. 2022. PMID: 35727562 Free PMC article.
References
-
- Bolukbasi Y, Selek U. Modern Radiotherapy Era in Breast Cancer. In: Pham PV, Selek U, editors. Breast Cancer: From Biology to Medicine. IntechOpen; London: 2017. p. 269.
-
- Khan M, Siddiqui SA, Gupta MK, et al. Normal Tissue Complications following Hypofractionated Chest Wall Radiotherapy in Breast Cancer Patients and Their Correlation with Patient, Tumor, and Treatment Characteristics. Indian J Med Paediatr Oncol. 2017;38(2):121–127. doi: 10.4103/ijmpo.ijmpo_80_16. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources